Andrew Alliance CEO, Piero Zucchelli, selected for SLAS Technology Editorial Board
Andrew Alliance is pleased to announce that our CEO, Piero Zucchelli, has been selected to join the SLAS Technology Editorial Board. SLAS Technology is a peer-reviewed and multi-disciplinary journal devoted to the advancement of life science technologies, with specific emphasis on scientific and technical advances that improve life science R&D. SLAS Technology recently doubled its impact factor to 2.85, and became one of the leading journals in the field. Andrew Alliance is proud of the opportunity to broadly support innovation in life science R&D with the goal of narrowing the gap between research achievements and available commercial solutions. We invite anybody in the Andrew Alliance community to contact [email protected] for possible interest in submission for publication.
Waters and Andrews Alliance Sign Co-Marketing Agreement
Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that will allow laboratories to meet the demands on them for glycan profiling while improving the accuracy and precision of LC and LC-MS results.
Andrew Pipetting Robot Featured in Waters Corporation ASMS Poster- Successfully Automating Glycan Analysis
Andrew Alliance was recently featured in a poster presentation from Waters Corporation during ASMS 2017 in Indianapolis. The poster discusses and presents the successful preparation of labeled N-glycans by means of using the Andrew robot in high sensitivity LC-MS analysis. The poster concludes the Andrew Alliance pipetting system can successfully and reproducibly perform GlycoWorks with RapiFluor-MS N-Glycan rapid labeling procedures. Use of the pipetting robot allows the analyst to free time and complete two jobs in parallel while maintaining high quality and reproducible scientific results
Andrew Alliance Awarded Top 100 Most Innovative Companies in Europe- Red Herring
Andrew Alliance has been awarded the Red Herring Europe recognition, a prestigious award that positions the company among the top 100 emerging private organizations across all industries on the continent.
Lumigen Inc. Presents Poster on Andrew Automating SPARCL Kit Product Line
Lumigen Inc. (A Beckman Coulter Company) presented a poster demonstrating the use of Andrew with their SPARCL Pharmacokinetic Immunoassay kits at the AAPS NBC event in San Diego. The poster summarizes Andrew’s accuracy and error free execution of the SPARCL kits leading to improved efficiency, reduced PK assay development and cost, all while increasing profitability. The specific poster relates to measuring IgG drug concentration in a pre-clinical setting.
